Fresh Equities

Raises

Markets

Learn

Looking for more information?

Contact our responsive and friendly client services team any time.

ASX:TDL logo

ASX:TDL

TBG Diagnostics Limited

Health Care / Biotechnology

Current price

$0.27

0.00 (0.00%)

Last trade: 26/09, 9:11AM

Market cap

$58.75m

Trading Suspended

Investor Presentations

Principal Activity

TBG Diagnostics Limited (TDL, formerly Progen Pharmaceuticals Limited) is a biotechnology company focused on the global molecular diagnostic industry and is involved in the development, manufacture and marketing of molecular diagnostic kits, instruments and services. The company's operating Segment includes � In Vitro Diagnostics. Former Names Progen Industries Limited (PGL), 02/04/2007; Progen Pharmaceuticals Limited (PGL), 02/02/2016


Address

Level 18/101 Collins St, Melbourne VIC 3000, Australia

News

Announcements

Filter

All categories
Investor Presentations
Trading Halt
Qtly Cashflow
Issued Capital
Periodic Reports
AnnouncementT+2 MovementDate

Rows per page:

5

0-0 of 0

Market Data

Day

3m

1yr

5yr

Current price

$0.27

Open price

-

Day low-high

-

Price change

-

Percent change

-

Previous close

-

Volume

-

Turnover

-

Bid price

-

Ask price

-

Market cap

-

Shares outstanding

-

Year high

-

Year low

-

Year low-high

-

Earnings per share

-

Price/earnings ratio

-

Dividend yield

-

Dividend per share

-

Franking

-

Investor Presentations

News

Sector Peers

CompanyMarket Cap
Fresh Equities
App Store
Play Store

Copyright © 2021 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9661 0441

clients@freshequities.com

Address

Level 19, 15 William St
Melbourne VIC 3000
Australia

App Store
Play Store

Copyright © 2021 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.